Sector
PharmaceuticalsOpen
₹4.1Prev. Close
₹4.15Turnover(Lac.)
₹14.14Day's High
₹4.3Day's Low
₹3.9552 Week's High
₹052 Week's Low
₹0Book Value
₹10Face Value
₹10Mkt Cap (₹ Cr.)
17P/E
0EPS
0Divi. Yield
0No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|
Equity Capital | 3.55 | 3.55 | 40 | 40 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 0 | 0 | -57.32 | -52.42 |
Net Worth | 3.55 | 3.55 | -17.32 | -12.42 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 1.83 | 19.96 | 41.53 | 52.83 |
yoy growth (%) | -90.82 | -51.92 | -21.4 | -16.02 |
Raw materials | -2.57 | -12.77 | -24.19 | -35.73 |
As % of sales | 140.47 | 63.99 | 58.26 | 67.62 |
Employee costs | -1.67 | -5.15 | -10.66 | -9.22 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | -4.93 | -4.14 | -8.79 | -7.71 |
Depreciation | -1.99 | -2.29 | -3.73 | -4.6 |
Tax paid | 0 | 0 | 0 | -7.9 |
Working capital | -2.05 | -18.82 | -18.57 | -22.8 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -90.82 | -51.92 | -21.4 | -16.02 |
Op profit growth | 80.81 | -64.58 | 125.44 | -461.18 |
EBIT growth | 27.24 | -54.65 | 84.32 | 352.73 |
Net profit growth | -58.1 | -82.11 | -15.79 | 2,102.81 |
| Particulars (Rupees in Crores.) | Mar-2018 | Mar-2017 | Mar-2016 | Mar-2015 | Mar-2014 |
|---|---|---|---|---|---|
Gross Sales | 41.85 | 55.67 | 122.89 | 189.86 | 191.58 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 41.85 | 55.67 | 122.89 | 189.86 | 191.58 |
Other Operating Income | 0 | 0 | 1.01 | 1.31 | 0 |
Other Income | 0.39 | 2.25 | 2.98 | 2.77 | 3.06 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,679.7 | 94.05 | 4,02,788.36 | 2,000.46 | 0.95 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,876 | 82.52 | 1,82,282.67 | 667 | 0.44 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,508.7 | 25.32 | 1,21,846.76 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,334.1 | 59.26 | 1,12,908.79 | 474 | 0.96 | 2,385 | 224.33 |
Dr Reddys Laboratories Ltd DRREDDY | 1,291.3 | 20.06 | 1,07,932.29 | 1,200.7 | 0.62 | 5,546.3 | 345.76 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Independent Director
Sunita Garg
Independent Director
Tushar Patodia
Managing Director
Ajay Shankarlal Bankda
Director
Manoj Negi
Independent Director
Bhishampal Singh Yadav
502 Advent Atria,
Chincholi Bunder Road Malad(W),
Maharashtra - 400064
Tel: 91-022-28813796/97
Website: http://www.syncomhealthcare.com
Email: complianceofficer@syncom.in
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: www.linkintime.co.in
Email: paytm.ipo@linkintime.co.in
Summary
Syncom Healthcare Ltd is engaged in the manufacture, marketing and trade of pharmaceutical formulations. The company manufactures a range of products such as Ethical drugs, Generic drugs, over the cou...
Read More
Reports by Syncom Healthcare Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.